Cargando…

Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables

Multiple lines of evidence indicate that immunological and inflammatory alterations contribute at least in a subgroup to the pathophysiology of schizophrenia. In this retrospective chart review, we investigated whether clinical factors contribute to altered cerebrospinal fluid (CSF) findings in schi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oviedo-Salcedo, Tatiana, Wagner, Elias, Campana, Mattia, Gagsteiger, Anna, Strube, Wolfgang, Eichhorn, Peter, Louiset, Marie-Luise, Luykx, Jurjen, de Witte, Lot D., Kahn, René S., Benros, Michael E., Falkai, Peter, Hasan, Alkomiet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654913/ https://www.ncbi.nlm.nih.gov/pubmed/34880213 http://dx.doi.org/10.1038/s41398-021-01751-7

Ejemplares similares

F107. CSF ABNORMALITIES IN SCHIZOPHRENIA AND DEPRESSION: PRELIMINARY RESULTS FROM A LARGE SCALE COHORT
por: Salcedo, Tatiana Oviedo, et al.
Publicado: (2018)

The relationship between blood–brain barrier dysfunction and neurocognitive impairments in first-episode psychosis: findings from a retrospective chart analysis
por: Maurus, Isabel, et al.
Publicado: (2023)

S177. FRONTAL CORTICAL PLASTICITY IN SCHIZOPHRENIA PATIENTS EXAMINED BY LTP-INDUCING ANODAL TDCS AND REPETITIVE EEG
por: Pross, Benjamin, et al.
Publicado: (2018)

Evaluation of evidence grades in psychiatry and psychotherapy guidelines
por: Löhrs, Lisa, et al.
Publicado: (2020)

The Influence of Continuous Exercising on Chronotropic Incompetence in Multi-Episode Schizophrenia
por: Herbsleb, Marco, et al.
Publicado: (2019)

11.3 CLINICAL AND NEUROBIOLOGICAL EFFECTS OF A CONTINUOUS AEROBIC ENDURANCE TRAINING IN MULTI-EPISODE SCHIZOPHRENIA PATIENTS
por: Malchow, Berend, et al.
Publicado: (2018)

Impairments of Motor-Cortex Responses to Unilateral and Bilateral Direct Current Stimulation in Schizophrenia
por: Hasan, Alkomiet, et al.
Publicado: (2013)

Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
por: Strube, Wolfgang, et al.
Publicado: (2022)

Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse
por: Wobrock, Thomas, et al.
Publicado: (2009)

Parameter-Based Evaluation of Attentional Impairments in Schizophrenia and Their Modulation by Prefrontal Transcranial Direct Current Stimulation
por: Gögler, Nadine, et al.
Publicado: (2017)

S192. EFFECTS OF NICOTINE INTAKE ON NEUROPLASTICITY IN SMOKING AND NON-SMOKING PATIENTS WITH SCHIZOPHRENIA
por: Pross, Benjamin, et al.
Publicado: (2020)

Bidirectional variability in motor cortex excitability modulation following 1 mA transcranial direct current stimulation in healthy participants
por: Strube, Wolfgang, et al.
Publicado: (2016)

T54. EFFECTS OF GAMMA TRANSCRANIAL ALTERNATING CURRENT STIMULATION TO THE LEFT DORSOLATERAL PREFRONTAL CORTEX ON WORKING MEMORY IN SCHIZOPHRENIA PATIENTS
por: Papazova, Irina, et al.
Publicado: (2020)

Schizophrenia as a disorder of disconnectivity
por: Schmitt, Andrea, et al.
Publicado: (2011)

The impact of environmental factors in severe psychiatric disorders
por: Schmitt, Andrea, et al.
Publicado: (2014)

Anodal transcranial direct current stimulation sustainably increases EEG alpha activity in patients with schizophrenia
por: Pross, Benjamin, et al.
Publicado: (2022)

Persistent catatonia following epileptic seizures: a case report and systematic literature search
por: Verbraeken, Ragnar, et al.
Publicado: (2018)

Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable, and multivariable Mendelian Randomization study
por: Luykx, Jurjen J., et al.
Publicado: (2021)

S79. ENHANCING WORKING MEMORY IN SCHIZOPHRENIA USING 1MA AND 2MA TRANSCRANIAL DIRECT STIMULATION TO THE LEFT DORSOLATERAL PREFRONTAL CORTEX
por: Papazova, Irina, et al.
Publicado: (2018)

Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
por: Hasan, Alkomiet, et al.
Publicado: (2020)

The Importance of Cerebrospinal Fluid Investigation in First-episode Psychosis
por: Pavăl, Denis, et al.
Publicado: (2023)

S47. ADD-ON SPIRONOLACTONE FOR THE TREATMENT OF SCHIZOPHRENIA (SPIRO TREAT)
por: Roeh, Astrid, et al.
Publicado: (2018)

Nonpharmacological treatment of dyscognition in schizophrenia: effects  of aerobic exercise 
por: Maurus, Isabel, et al.
Publicado: (2019)

T53. NEUROPHYSIOLOGICAL AND BEHAVIORAL EFFECTS OF THE STIMULATION OF NICOTINIC RECEPTORS AND NON-INVASIVE BRAIN STIMULATION IN PATIENTS WITH SCHIZOPHRENIA: STUDY DESIGN AND METHODOLOGY OF A RANDOMIZED CONTROLLED TRIAL
por: Güler, Duygu, et al.
Publicado: (2020)

Biomarkers in the Cerebrospinal Fluid of Patients with Psychotic Disorders Compared to Healthy Controls: A Systematic Review and Meta-Analysis
por: Rømer, T., et al.
Publicado: (2022)

Season of Sampling and Season of Birth Influence Serotonin Metabolite Levels in Human Cerebrospinal Fluid
por: Luykx, Jurjen J., et al.
Publicado: (2012)

Subjective burden and perspectives of German healthcare workers during the COVID-19 pandemic
por: Kramer, Victoria, et al.
Publicado: (2020)

Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review
por: Wagner, Elias, et al.
Publicado: (2021)

BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
por: Strube, Wolfgang, et al.
Publicado: (2015)

Coding and Non-Coding RNA Abnormalities in Bipolar Disorder
por: Luykx, Jurjen J., et al.
Publicado: (2019)

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence
por: Malchow, Berend, et al.
Publicado: (2012)

A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
por: ter Hark, Sophie E, et al.
Publicado: (2020)

Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression – a study protocol
por: Sørensen, Nina Vindegaard, et al.
Publicado: (2022)

Depression in Somatic Disorders: Is There a Beneficial Effect of Exercise?
por: Roeh, Astrid, et al.
Publicado: (2019)

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
por: Luykx, Jurjen J., et al.
Publicado: (2020)

T204. CLOZAPINE COMBINATION AND AUGMENTATION STRATEGIES IN PATIENTS WITH SCHIZOPHRENIA –RECOMMENDATIONS FROM AN INTERNATIONAL EXPERT SURVEY AMONG THE TREATMENT RESPONSE AND RESISTANCE IN PSYCHOSIS (TRRIP) WORKING GROUP
por: Wagner, Elias, et al.
Publicado: (2020)

Peripheral blood gene expression profiles linked to monoamine metabolite levels in cerebrospinal fluid
por: Luykx, J J, et al.
Publicado: (2016)

Efficacy and Interindividual Variability in Motor-Cortex Plasticity following Anodal tDCS and Paired-Associative Stimulation
por: Strube, Wolfgang, et al.
Publicado: (2015)

Corrigendum to “Efficacy and Interindividual Variability in Motor-Cortex Plasticity following Anodal tDCS and Paired-Associative Stimulation”
por: Strube, Wolfgang, et al.
Publicado: (2015)

S207. TDCS AS FUTURE TREATMENT OPTION FOR SCHIZOPHRENIA PATIENTS - A NEUROPHYSIOLOGICAL INVESTIGATION OF INDUCED PLASTICITY OVER MOTOR AND PREFRONTAL CORTEX USING SLORETA
por: Filipova, Nina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_11fsc511mkvid9cgntl84cpkor